San Diego-based MabVax Therapeutics Holdings Inc., an oncology company working on cancer vaccines, has entered into a research collaboration with The Rockefeller University.

The two will explore ways to make antibodies more effective at fighting certain tumors.

The work will be conducted in the Laboratory of Molecular Genetics and Immunology at The Rockefeller University, and headed by Dr. Jeffery Ravetch.